Printer Friendly

TargetRx Awarded Patent for Innovative Method of Predicting Prescribing Behavior.

Patented Approach Enables Pharmaceutical Companies to Focus Effort on the Drivers of Prescribing and Improving Effectiveness

HORSHAM, Pa. -- TargetRx, a pharmaceutical sales and marketing effectiveness company, today announced that it has been awarded a patent by the United States Patent and Trademark Office (U.S. Patent #7,080,027), titled "Method and System for Analyzing the Effectiveness of Marketing Strategies." Demonstrating the company's continued commitment to innovation, this newly patented method of predicting prescribing behavior allows TargetRx to provide highly actionable insights that help pharmaceutical companies improve sales and marketing performance.

TargetRx has revolutionized the industry's approach to evaluating sales and marketing effectiveness by focusing on how well a company influences physicians to prescribe its products for appropriate patients. Over the past six years, TargetRx has built a unique and powerful database of 200 million responses to questions collected from more than 70,000 U.S. physicians. The information that TargetRx derives from this database allows pharmaceutical companies to understand specific opportunities to grow market share and to make the best decisions regarding their sales and marketing initiatives. More specifically, with its patented analysis, TargetRx predicts prescribing behavior, uncovers the drivers of that behavior, and clearly identifies the actions that affect prescribing most effectively.

"This patent reinforces the unique power of our approach and our continued dedication to improving our clients' performance by providing valuable and actionable insight in a way that no other company can," said Mike Luby, CEO of TargetRx. "Our 'Method for Analyzing the Effectiveness of Marketing Strategies' is sound and proven to deliver high quality sales and marketing insights that help pharmaceutical companies make better-informed, strategic decisions that will ultimately increase physician prescribing."

About TargetRx

TargetRx is a pharmaceutical sales and marketing effectiveness company that provides actionable insight to pharmaceutical companies to help them effectively sell and market their products and improve their financial performance. TargetRx has developed a highly predictive database of physician attitudes that it uses in combination with its patented analytic methods to provide pharmaceutical companies with powerful "leading indicators" of how their sales and marketing initiatives will affect physician prescribing. TargetRx benchmarks performance, identifies immediate improvement opportunities and predicts future performance for its clients. TargetRx works with the majority of the top 30 pharmaceutical companies in the U.S. For further information, visit
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 2, 2006
Previous Article:Webcast Alert: Gastar Exploration, Ltd. Announces Its 2006 OGIS West Investment Symposium Webcast.
Next Article:Working Wiper Blades Increase Visibility, Decrease Accidents.

Related Articles
"Appplication of mathematical methods to problems in market research and advertising". (Retrospect).
Should I Medicate my Child? Sane Solutions for Troubled Kids with--and without--Psychiatric Drugs.
Graduate cooperative groups: role of perfectionism.
RightNow granted new patent.
Farris, Caretta and Ellul to be honored.
Models predict pathogen behavior.
In this issue.
Using the theory of reasoned action to explain physician intention to prescribe emergency contraception.
Spring series of FSCT Virtual Learning Conferences features two-part course on cure characterization.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters